The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs

COVID-19 is a highly contagious respiratory disease, which mainly affects the lungs. Critically ill patients are easily complicated by cytokine storms, acute respiratory distress syndrome (ARDS), and respiratory failure, which seriously threaten their lives. Pulmonary fibrosis (PF) is a common inter...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Hao Shen, Nu Zhang, Yuqing Liu, Xuerong Yang, Yuanyuan He, Qi Li, Xiaoyan Shen, Yulian Zhu, Yong Yang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2022-01-01
Edice:	Frontiers in Pharmacology
Témata:	pulmonary fibrosis COVID-19 mechanism interaction drug treatment
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fphar.2021.805535/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!